We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Alcon Pharmaceuticals is asking the FDA to apply stricter requirements on bioequivalence studies intended to supplement applications for Durezol and Ciprodex generics. Read More
A federal judge awarded Fresenius a preliminary injunction that blocks Fera Pharmaceuticals from marketing a levothyroxine sodium generic for the treatment of an underactive thyroid. Read More
The UK’s price watchdog has recommended reimbursement for Alexion Pharma’s Strensiq to treat perinatal- and infantile-onset hypophosphatasia and Gilead’s Epclusa to block the spread of hepatitis C virus genotypes to new cells, provided the companies discount the prices. Read More
A group of pharmaceutical companies has filed a joint amicus brief defending ex-Acclarent executives William Facteau and Patrick Fabian, urging a federal court to acquit them of misdemeanor charges. Read More
The Senate approved a bill extending the FDA’s program that offers priority review vouchers for rare pediatric disease treatments Sept. 22, one week before the program’s set expiration date. Read More